NEU 0.15% $13.13 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,043 Posts.
    lightbulb Created with Sketch. 249
    Global improvements - absolutely the best we could have hoped for. So happy for the people that will benefit from this drug in years to come. A few more years is worth the wait if you have a child with no other treatment options.

    Well done Neuren, and congrats - all shareholders!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.13
Change
0.020(0.15%)
Mkt cap ! $1.678B
Open High Low Value Volume
$13.20 $13.44 $13.07 $5.021M 378.7K

Buyers (Bids)

No. Vol. Price($)
4 11501 $13.12
 

Sellers (Offers)

Price($) Vol. No.
$13.18 1539 1
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.